Hong Liu

Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-CoV-2 PLpro.

Yi Zang, Bin Song, Ning Song, 2024, Antiviral research.

Discovery and characterization of novel potent non-covalent small molecule inhibitors targeting papain-like protease from SARS-CoV-2

Xinheng He, Yi Zang, Zhidong Jiang, 2024, Acta pharmaceutica Sinica. B.

Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors

Yu Zhou, Chunpu Li, Yin-chun Ji, 2023, Acta pharmaceutica Sinica. B.